Kara Doyle
Family · Vincennes, INNPI 1841547726
Payments from drug & device makers
Across 223 payments — averaging $14.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$540
- Novo Nordisk$512
- Amgen$450
- Pfizer$259
- Lilly USA, LLC$255
- Ironshore Pharmaceuticals Inc.$132
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,188100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $540 |
| Novo Nordisk | 37 | $512 |
| Amgen(2 entities) | 31 | $450 |
| Pfizer | 19 | $259 |
| Lilly USA, LLC | 17 | $255 |
| Ironshore Pharmaceuticals Inc. | 8 | $132 |
| Bayer | 7 | $103 |
| Collegium Pharmaceutical, Inc. | 5 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $78 |
| Otsuka America Pharmaceutical, Inc. | 5 | $72 |
| GSK | 4 | $60 |
| Exact Sciences | 4 | $59 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $48 |
| Merck | 3 | $45 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
| Corium, LLC | 3 | $45 |
| Dexcom, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $30 |
| Covis Pharma GmbH | 2 | $25 |
| Ardelyx, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Stryker | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$3,188 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 22 | $22,965 |
| MounjaroTirzepatide | 17 | $18,252 |
| LinzessLinaclotide | 18 | $15,061 |
| TrulicityDulaglutide | 12 | $11,713 |
| EliquisApixaban | 12 | $6,708 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,280 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,294 |
| Modafinil | 12 | $1,083 |
| ValacyclovirValacyclovir Hcl | 21 | $1,077 |
| Celecoxib | 38 | $975 |
| Levothyroxine Sodium | 101 | $696 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $525 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $496 |
| Rosuvastatin Calcium | 75 | $480 |
| Omeprazole | 77 | $436 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $255 | $29,96529 claims |
| Boehringer IngelheimJardiance | $30 | $22,96522 claims |
| AbbVieLinzess | $540 | $15,06118 claims |
| PfizerEliquis | $259 | $6,70812 claims |
| GSKArnuity Ellipta | $60 | $2,28011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.
Other family in Vincennes
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.